ACRS

News Aclaris Therapeutics GAAP EPS of -$0.15 beats by $0.01, revenue of $2M beats by $0.68M

26d ago

SEC filing ACRS Reports $1.2M Revenue, $0.01 EPS, +150% YoY, Launches Phase 2b ATI-052 Asthma Trial, $200M Cash Runway Through 2028

26d ago

Insider trade Sale by Braden Michael Leonard

35d ago

News Aclara Sees Prospect of Fast-Tracking Rare Earth Project With Chile’s Next President

141d ago

News Aclarion Provides 2025 Update and 2026 Corporate Outlook

145d ago